Steven Cohen’s Tango Therapeutics TNGX Stock Holding History

Steven Cohen’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.33M	Sell	298,339 -235,598	-44%	-$5.82M	0.01%	1332
2026 Q1	$11.2M	Sell	533,937 -1,440,098	-73%	-$20M	0.01%	1165
2025 Q4	$17.5M	Sell	1,974,035 -945,415	-32%	-$8.15M	0.02%	987
2025 Q3	$24.5M	Buy	+2,919,450	New	+$19.8M	0.04%	489
2024 Q3	–	Sell	-447,107	Closed	-$3.84M	–	2350
2024 Q2	$3.84M	Buy	+447,107	New	+$3.45M	0.01%	922
2023 Q2	–	Sell	-7,346	Closed	-$29K	–	2782
2023 Q1	$29K	Buy	+7,346	New	+$42.6K	﹤0.01%	1907

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Steven Cohen's TNGX Position: Q2 2026 in Review

Steven Cohen reduced its Tango Therapeutics (TNGX) stake by 44% in Q2 2026, selling an estimated $5.82M and leaving 298,339 shares worth $9.33M. The position accounts for 0.01% of the portfolio, ranked #1332.

Steven Cohen first reported a position in TNGX in Q1 2023 and has held it in 6 quarters since. The position peaked at $24.5M in Q3 2025. 246 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Steven Cohen held 298,339 shares of Tango Therapeutics worth $9.33M as of Q2 2026.
Steven Cohen sold 235,598 Tango Therapeutics shares in Q2 2026, an estimated $5.82M.
Tango Therapeutics made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1332 holding.
Steven Cohen first reported a position in Tango Therapeutics in Q1 2023 and has held it in 6 quarters since.
Steven Cohen's Tango Therapeutics position peaked at $24.5M in Q3 2025.
246 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.